Agranulocytosis secondary to cancer chemotherapy Notes: code for adverse effect, if applicable, to identify drug (T45.1X5)
D72.12 Drug rash with eosinophilia and systemic symptoms syndrome Notes: DRESS syndrome ; code for adverse effect, if applicabl…
Drug rash with eosinophilia and systemic symptoms syndrome Notes: DRESS syndrome ; code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
D72.829 Elevated white blood cell count, unspecified Notes: Elevated leukocytes, unspecified ; Leukocytosis, unspecified
Elevated white blood cell count, unspecified Notes: Elevated leukocytes, unspecified ; Leukocytosis, unspecified
D74.8 Other methemoglobinemias Notes: Acquired methemoglobinemia (with sulfhemoglobinemia) ; Toxic methemoglobinemia
Other methemoglobinemias Notes: Acquired methemoglobinemia (with sulfhemoglobinemia) ; Toxic methemoglobinemia
D75.89 Other specified diseases of blood and blood-forming organs
Other specified diseases of blood and blood-forming organs
D78.22 Postprocedural hemorrhage of the spleen following other procedure
Postprocedural hemorrhage of the spleen following other procedure
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia
D70.2 Other drug-induced agranulocytosis Notes: code for adverse effect, if applicable, to identify drug (T36-T50 with fifth o…
Other drug-induced agranulocytosis Notes: code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)